
 
 
  This drug entry is a  stub  and has not been fully annotated. It is scheduled to be annotated soon.  Identification Generic Name (12R)-12-hydroxyeicosapentaenoic acid DrugBank Accession Number DB15571 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (12R)-12-hydroxyeicosapentaenoic acid (DB15571) ×  Close Weight Average: 318.457  Monoisotopic: 318.219494826  Chemical Formula C 20 H 30 O 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Not Available Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Products Drug product information from 10+ global regions Our datasets provide approved product information including: dosage, form, labeller, route of administration, and marketing period. Access now     Access drug product information from over 10 global regions. Access now Unapproved/Other Products  
 
 
 Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Luvira (12R)-12-hydroxyeicosapentaenoic acid  (465 mg/1)  +  Doconexent   (375 mg/1)  +  Omega-3-acid ethyl esters   (1220 mg/1) Capsule Oral Sterling-Knight Pharmaceuticals, LLC 2019-11-07 2020-01-17 US Luvira (12R)-12-hydroxyeicosapentaenoic acid  (465 mg/1)  +  Doconexent   (375 mg/1)  +  Omega-3 fatty acids   (1220 mg/1) Capsule Oral Sterling-Knight Pharmaceuticals, LLC 2020-01-17 Not applicable US Categories Drug Categories Not Available Classification Not classified Affected organisms Not Available Chemical Identifiers UNII 78P2ZC128S CAS number 109430-12-8 InChI Key MCRJLMXYVFDXLS-IHWYZUJNSA-N InChI InChI=1S/C20H30O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h3-4,7-11,13-14,17,19,21H,2,5-6,12,15-16,18H2,1H3,(H,22,23)/b4-3-,9-7-,11-8-,13-10-,17-14+/t19-/m1/s1 IUPAC Name (5Z,8Z,10E,12R,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid SMILES CC\C=C/C\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O References General References Not Available External Links ChemSpider 4446312 RxNav 2261372 ZINC ZINC000014449721 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Form Route Strength Capsule Oral Prices Not Available Patents Not Available Properties State Not Available Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00305 mg/mL ALOGPS logP 5.54 ALOGPS logP 4.99 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 4.89 Chemaxon pKa (Strongest Basic) -1.6 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 57.53 Å 2 Chemaxon Rotatable Bond Count 13 Chemaxon Refractivity 102.59 m 3 ·mol -1 Chemaxon Polarizability 37.19 Å 3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Not Available Spectra Mass Spec (NIST) Not Available Spectra Not Available × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at November 18, 2019 16:05 / Updated at June 12, 2020 16:53 